Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Phil Gutis
Phil’s Journal: After My Early Onset Alzheimer’s Diagnosis, Writing About It Became Cathartic
$350 Million to Be Given to Alzheimer’s Research in 2020 Funding Bill
There’s More to Alzheimer’s Than Your Genes: Researchers Find Clues By Studying Identical Triplets
Can Coffee Protect Your Brain From Alzheimer’s?
Phil’s Journal: Seeking to Understand the Science Behind Biogen’s Alzheimer’s Drug
Biogen Reports Drug Effective in Slowing Alzheimer’s Disease: ‘A Milestone Achievement’
Positive Results in Treating Dementia-Related Psychosis With Pimavanserin
How Ultrasounds May Help Treat Alzheimer’s: Passing the Blood-Brain Barrier
Clinical Trials on Alzheimer’s Disease Conference 2019: What to Look Out For
How Blood Sugar Levels Affect Your Brain: Type 2 Diabetes, Hypoglycemia, and Dementia
Early Onset Alzheimer’s: 5 Signs to Look Out For, and How to Address Them
50% of Americans Worry About Dementia — Many Unaware of Preventive Steps
Long-Term Changes in Blood Pressure Linked to Increased Dementia Risk
What Does the APOE3 Genetic Variant Mean for Alzheimer’s?
Could China’s ‘Seaweed Drug’ Treat Alzheimer’s? Experts Remain Cautious
Previous
4
5
6
Next
Page load link
Go to Top